KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas-Reference-Cited by-同舟云学术

KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas

Published:2013-07-02 Issue:7 Volume:14 Page:13748-13762
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rahman Mohammed,Nakayama Kentaro,Rahman Munmun,Katagiri Hiroshi,Katagiri Atsuko,Ishibashi Tomoka,Ishikawa Masako,Sato Emi,Iida Kouji,Nakayama Naomi,Ishikawa Noriyuki,Miyazaki Kohji

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/14/7/13748/pdf

Reference24 articles.

1. Cancer statistics 1995;Wingo;CA Cancer J. Clin,1995

2. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma;Hoskins;Am. J. Obstet. Gynecol,1994

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study;Ozols;J. Clin. Oncol,2003

4. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Engl. J. Med,1996

5. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm;Kurman;Hum. Pathol.,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma;BMC Cancer;2024-02-05

2. Identification of microRNA and protein interaction networks in human ovarian cancer;Research Journal of Biotechnology;2023-09-15

3. Dual targeting in prostate cancer with phytoconstituents as a potent lead: a computational approach for novel drug discovery;Journal of Biomolecular Structure and Dynamics;2023-08-30

4. Chromosome 22;Cancer Genes: Volume 2;2023-08-16

5. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in Ovarian Cancer Patients: Evidence from Bioinformatics and In Vitro Level;Computational and Mathematical Methods in Medicine;2022-10-14